Navigation Links
CuraGen Reports Second Quarter 2009 Financial Results
Date:7/31/2009

BRANFORD, Conn., July 31 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) today reported its financial results for the second quarter of 2009 and announced that it had further reduced its outstanding convertible debt and reached an agreement in principle, expressed in a memorandum of understanding, to settle recent shareholder class action lawsuits filed in the State of Connecticut and the State of Delaware in connection with the proposed merger between CuraGen Corporation and Celldex Therapeutics, Inc. The settlement is subject to documentation and court approval.

During the three and six month periods ended June 30, 2009, CuraGen utilized $3.8 million and $7.8 million, respectively, of cash and investments for operations, which includes cash paid for legal, audit and strategic advisor fees of $0.6 million and $0.7 million for the three and six month periods ended June 30, 2009, respectively. As of June 30, 2009, CuraGen had $76 million of cash and investments and $14.1 million of 4% convertible subordinated notes due February 2011. CuraGen repurchased $1.64 million of its 4% convertible subordinated notes for $1.39 million in July 2009 and as of July 31, 2009, had $12.5 million of 4% convertible subordinated notes outstanding. During 2009, through privately negotiated transactions, CuraGen has repurchased $6.5 million of convertible subordinated notes at an average cost of 80% of par.

For the three and six months ended June 30, 2009, CuraGen reported total operating expenses of $4.7 and $8.3 million, respectively, which included costs incurred for legal, audit and strategic advisor fees of $1.5 million and $1.6 million for the three and six month periods ended June 30, 2009, respectively.

CuraGen is continuing to enroll patients in c
'/>"/>

SOURCE CuraGen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
2. CuraGen Reports Third Quarter 2008 Financial Results
3. CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
4. CuraGen Sells Ownership of Belinostat to TopoTarget A/S
5. CuraGen to Present at the BIO CEO & Investor Conference
6. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
7. CuraGen Corporation Receives Notification from NASDAQ
8. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
9. CuraGen and TopoTarget Announce Initiation of an NCI-sponsored Phase II Clinical Trial of Belinostat for Thymoma and Thymic Carcinoma
10. CuraGen to Present at the 19th Annual Piper Jaffray Health Care Conference
11. CuraGen Appoints Clinical Oncologist as VP of Medical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... ActiGraph, a leading provider of objective physical ... community, announced today that Dr. Victor KR Matsudo has ... Scientific Director of the Physical Fitness Research Center of ... at Gama Filho University and the Chairman of the ... of Health of São Paulo State, Brazil. , ...
(Date:6/18/2013)... June 18, 2013 NuView Life Sciences ... and in vitro diagnostic (IVD) biomarkers, today announced the ... urine screen in development for the early detection of ... in an oral presentation at the 2013 Annual Meeting ... (SNMMI) in Vancouver, Canada on Sunday, June 9th. ...
(Date:6/17/2013)... CAMBRIDGE, MA (PRWEB) June 17, 2013 ... (AQM) system in March that helps better monitor potentially ... Station. The microAnalyzer V2.0, which was developed by ... International Space Station. , Astronauts breathe air that is ... exposure to harmful compounds in the air, even in ...
Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2
... 21 Sequenom, Inc. (NASDAQ: SQNM ), a ... it will report financial results for the second quarter of ... August 4, 2011. A conference call hosted by ... members of senior management will take place on the same ...
... BioSciences, Inc. (Nasdaq: SGMO ) today announced that ... on Wednesday, July 27, 2011, after the market closes. The ... 5:00 p.m. ET, which will be open to the public ... will review the financial results and discuss other business matters. ...
... , Daval International announced the completion ... blind Phase II,Study, Treating Patients with Bladder Dysfunction ... clinical,measures and assessment scores recorded on patients who ... used to investigate safety,efficacy and response to treatment. ...
Cached Biology Technology:Sequenom, Inc. Announces Date of Second Quarter 2011 Financial Results and Conference Call 2Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 3
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
(Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
... weed is another man,s wonder and University of Guam research ... his career finding environmentally safe methods to control invasive plants. ... and coauthor of the book Biological Control of Tropical ... the Cambridge University Press and available to the public in ...
... signs of climate change in the upper atmosphere and ... Tyler Prize for Environmental Achievement. The award, ... will go to Richard Alley, professor of geosciences at ... atmospheric and climate sciences in the Scripps Institution of ...
... release is available in French and Spanish ... more than 160 endorsed science projects assembled from researchers in ... covers a two-year period to March 2009 to allow for ... joint project of WMO and ICSU, IPY spearheaded efforts to ...
Cached Biology News:Winners of Tyler environmental prize announced 2Polar research reveals new evidence of global environmental change 2Polar research reveals new evidence of global environmental change 3
Request Info...
QML offers standard and customized paraffin embedded tissue blocks....
Use our experts and resources to develop reagent systems for your applications....
Request Info...
Biology Products: